Novavax, Inc. (NVAX) return on equity (ROE)

Return on equity · fiscal 2020
-66.7%

Novavax, Inc. (NVAX) earned a return on equity of -66.7% in fiscal 2020 (the year ended December 31, 2020). Figures as of 18 Nov 2026, 03:16 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Return on equity, fiscal 2020
-66.7%
Highest on record
-25.6%fiscal 2013
Lowest on record
-66.7%fiscal 2020
Fiscal years on record
82009–2020

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Novavax, Inc. return on equity (ROE), in more detail

Across the 8 fiscal years on record (2009–2020), the highest was -25.6% in fiscal 2013 and the lowest -66.7% in fiscal 2020. The fiscal 2020 figure is no higher than in any of the 7 earlier fiscal years on record, whose median is -36.1%.

History · 8 fiscal years

Return on equity by fiscal year

Novavax, Inc. return on equity (ROE), year by year

Novavax, Inc. (NVAX) return on equity (ROE) by fiscal year
Fiscal yearReturn on equityChangeYear ended
2020-66.7%—
2015-53.6% 17.5 pts down
2014-36.1% 10.5 pts down
2013-25.6% 9.9 pts up
2012-35.5% 0.4 pts up
2011-36.0% 24.5 pts up
2010-60.5% 2.8 pts down
2009-57.7%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

How to read it

It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.

More on NVAX

Novavax, Inc., figure by figure

Novavax, Inc. (NVAX) overview: price, valuation and scorecard

Novavax, Inc. return on equity (ROE): questions and answers

What is Novavax, Inc.'s return on equity?

Novavax, Inc. (NVAX) earned a return on equity of -66.7% in fiscal 2020 (the year ended December 31, 2020).

Is Novavax, Inc.'s return on equity high or low compared with its own history?

The fiscal 2020 figure is no higher than in any of the 7 earlier fiscal years on record, whose median is -36.1%.

What are the highest and lowest return on equity figures on record for Novavax, Inc.?

Across the 8 fiscal years on record (2009–2020), the highest was -25.6% in fiscal 2013 and the lowest -66.7% in fiscal 2020.

How is Novavax, Inc.'s return on equity calculated?

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Novavax, Inc. (NVAX) return on equity (ROE)”, data as of 18 November 2026. https://funkfolio.com/stock/NVAX/roe

Underlying data: the company's filings with the SEC and Yahoo Finance.